Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Umm Al Emarat Park welcomes back The Cove House for its second edition, running from 5 to 8 February, unveiling a new Wonderland-inspired experience designed to spark imagination, creativity, and discovery.    This year’s edition places a strong focus on shared experiences that celebrate cultural connection and family togetherness through collaborative and interactive activities, aligning […] The post The Cove House Unveils a New Wonderland Experience at Umm Al Emarat Park appeared first on Web-Release.